湘南学院学报(医学版)
湘南學院學報(醫學版)
상남학원학보(의학판)
JOURNAL OF XIANGNAN UNIVERSITY(MEDICAL SCIENCES)
2014年
4期
26-28
,共3页
曹苏娟%周定中%李庆%张忠山
曹囌娟%週定中%李慶%張忠山
조소연%주정중%리경%장충산
结直肠癌%肝转移%热灌注%化疗%介入治疗
結直腸癌%肝轉移%熱灌註%化療%介入治療
결직장암%간전이%열관주%화료%개입치료
Colorectal carcinoma%Hepatic metastases%Thermal perfusion%Chemotherapy%Interventional therapy
目的评价肝动脉热灌注化疗联合TACE治疗结直肠癌肝转移的临床效果和安全性。方法70例结直肠癌肝转移患者随机分为治疗组(n=35)和对照组(n=35),治疗组采取肝动脉热灌注化疗联合TACE,对照组常温动脉化疗联合TACE,两次治疗间隔1月,3个周期后评价临床疗效、生活质量和不良反应。结果治疗组和对照组有效率分别为65.7%(23/35)和40.0%(14/35),差异有统计学意义(x2=5.64,P<0.05),治疗组的生活质量也明显改善(x2=5.41,P<0.05)。不良反应比较两组差异无统计学意义。结论肝动脉热灌注化疗联合TACE治疗结直肠癌肝转移具有较好的临床效果,可以提高患者生活质量。
目的評價肝動脈熱灌註化療聯閤TACE治療結直腸癌肝轉移的臨床效果和安全性。方法70例結直腸癌肝轉移患者隨機分為治療組(n=35)和對照組(n=35),治療組採取肝動脈熱灌註化療聯閤TACE,對照組常溫動脈化療聯閤TACE,兩次治療間隔1月,3箇週期後評價臨床療效、生活質量和不良反應。結果治療組和對照組有效率分彆為65.7%(23/35)和40.0%(14/35),差異有統計學意義(x2=5.64,P<0.05),治療組的生活質量也明顯改善(x2=5.41,P<0.05)。不良反應比較兩組差異無統計學意義。結論肝動脈熱灌註化療聯閤TACE治療結直腸癌肝轉移具有較好的臨床效果,可以提高患者生活質量。
목적평개간동맥열관주화료연합TACE치료결직장암간전이적림상효과화안전성。방법70례결직장암간전이환자수궤분위치료조(n=35)화대조조(n=35),치료조채취간동맥열관주화료연합TACE,대조조상온동맥화료연합TACE,량차치료간격1월,3개주기후평개림상료효、생활질량화불량반응。결과치료조화대조조유효솔분별위65.7%(23/35)화40.0%(14/35),차이유통계학의의(x2=5.64,P<0.05),치료조적생활질량야명현개선(x2=5.41,P<0.05)。불량반응비교량조차이무통계학의의。결론간동맥열관주화료연합TACE치료결직장암간전이구유교호적림상효과,가이제고환자생활질량。
Objective To evaluate the clinical effect and safety of transcatheter hepatic arterial thermo_chemotherapy combined with transcatheter arterial chemoembolization ( TACE ) for the treatment of hepatic metastases from colorectal carcinoma. Methods Totally 70 cases of hepatic metastases from colorectal carci_noma were randomly divided into treatment group(n=35) and control group(n=35). The patients in treat_ment group were treated with transcatheter hepatic arterial thermochemotherapy combined with TACE,while the patients in the control group with conventional( normal temperature) transcatheter hepatic arterial chemo_therapy combined with TACE. The treatment was repeated every month. The clinical effect, tosicity and quality of life were analyzed after three months. Results Treatment effect is 65. 7% (23/35) in treatment group and 40. 0%(14/35) in control group,the difference between two groups was statistically significant(x2=5. 64,P<0. 05). The quality of life was improved in treatment group than that of control group(x2=5. 41, <br> P<0. 05). The side effects were found in two groups without significant difference. Conclusion Transcatheter hepatic arterial thermochemotherapy combined with TACE for the treatment of hepatic metastases from color_ectal carcinoma can increase the clinical effect and improve the quality of life.